RT @GlobalAgendaKB: 今年の5月にNature誌に掲載された論文。#コロナ・ワクチン の供給に関する重要な指摘。製薬会社だけが利益を得るのでなく、きちんと低コストで世界の人々に届かないと意味がない。 https://t.co/yYWljoQaSo
RT @GlobalAgendaKB: 今年の5月にNature誌に掲載された論文。#コロナ・ワクチン の供給に関する重要な指摘。製薬会社だけが利益を得るのでなく、きちんと低コストで世界の人々に届かないと意味がない。 https://t.co/yYWljoQaSo
今年の5月にNature誌に掲載された論文。#コロナ・ワクチン の供給に関する重要な指摘。製薬会社だけが利益を得るのでなく、きちんと低コストで世界の人々に届かないと意味がない。 https://t.co/yYWljoQaSo
Una vez que medicamentos y/o vacunas contra #COVID19 estén disponibles, los derechos de #PropiedadIntelectual no deben impedir el acceso para todos https://t.co/q39GLMzD5v
Una vez que medicamentos y/o vacunas para #COVID19 estén disponibles, los derechos de #PropiedadIntelectual no deben impedir el acceso para todos https://t.co/q39GLMzD5v
RT @franciscocho: "Products for the prevention and treatment of COVID-19 should be global public goods. But saying so does not make it so.…
RT @franciscocho: "Products for the prevention and treatment of COVID-19 should be global public goods. But saying so does not make it so.…
#PublicHealth Protect against market exclusivity in the fight against COVID-19 https://t.co/4nQ0RlC0DN @ellenthoen @nature https://t.co/CBOtcIZrPN
This is unfortunate. Patents or IPR should be either pooled or purchased by global community (?) so that drugs/vaccines can be produced by any country and made available quickly and cheaply to whole world.
"Products for the prevention and treatment of COVID-19 should be global public goods. But saying so does not make it so. That requires action at the global level"
RT @schestowitz: #Lancet has since then been corrupted by #billgates https://t.co/MrPZEB3VAn see 1) before: https://t.co/iHQetzQVzz 2) afte…
#Lancet has since then been corrupted by #billgates https://t.co/MrPZEB3VAn see 1) before: https://t.co/iHQetzQVzz 2) after: https://t.co/xQlidHfFDe
Sanofi: During the A/H1N1 influenza pandemic in 2009, wealthy nations negotiated advanced orders of vaccine, to the detriment of developing countries (G. Yamey et al. Lancet https://t.co/BL0QI2QHBp 10.1016/S0140-6736(20)30763-7; 2020) https://t.co/pE7DDkXq
Don't destroy incentive
@NatureMedicine "Existe una preocupación legítima de que la industria farmacéutica buscará proteger sus intereses comerciales en esta crisis, en detrimento del acceso universal" En: https://t.co/oDXONvAB6y
Upajmo, da se ne bo ponovila zgodba z maskami. Če vidite oglas za razna cepiva pred januarjem, ne nasedajte. Cepivo radi čas, da je kvalitetno in testirano. Upajmo, da to krizo za denar izkoristiti čim manj ljudi. ❤️
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @PEB_COPPE_UFRJ: Artigo de Emma Levie, Protect against market exclusivity in the fight against COVID-19Patents and other intellectual pr…
Artigo de Emma Levie, Protect against market exclusivity in the fight against COVID-19Patents and other intellectual properties could slow down the scale-up and accessibility of treatments and vaccines against COVID-19. Acesso: https://t.co/tiP0rnkWKD
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
The COVID-19 technology pool should be front and center in the strategy against COVID-19 to ensure that once medicines and vaccines become available, intellectual property will not be the barrier to making them accessible for all in need. @ellenthoen http
RT @Alzhacker: https://t.co/UNiPshQ6GG ワクチンの特許やその他の知的財産は、COVID-19に対する治療法やワクチンのスケールアップやアクセスを遅らせる可能性がある。
RT @Alzhacker: https://t.co/UNiPshQ6GG ワクチンの特許やその他の知的財産は、COVID-19に対する治療法やワクチンのスケールアップやアクセスを遅らせる可能性がある。
https://t.co/UNiPshQ6GG ワクチンの特許やその他の知的財産は、COVID-19に対する治療法やワクチンのスケールアップやアクセスを遅らせる可能性がある。
@ellenthoen, writing in @nature, argues that all countries should agree (through @WHO) to encourage (oblige?) companies to pool patents for #COVID19 meds and vaccines, so they can be easily licensed for production for poorer markets. https://t.co/8yNDIsSKR
RT @CyrilPedia: 'There is legitimate concern that the pharmaceutical industry will be looking to protect their commercial interests in this…
'There is legitimate concern that the pharmaceutical industry will be looking to protect their commercial interests in this crisis, to the detriment of universal access.' https://t.co/K6lY6obkLU
RT @uranus_2: 特許等の市場独占権が新型コロナウイルス感染症対策の妨げになってはならない。そのためには、新型コロナウイルス感染症に関わるテクノロジープールを推進する必要がある。Protect against market exclusivity in the fig…
特許等の市場独占権が新型コロナウイルス感染症対策の妨げになってはならない。そのためには、新型コロナウイルス感染症に関わるテクノロジープールを推進する必要がある。Protect against market exclusivity in the fight against COVID-19 https://t.co/QBnElVNmhE
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @markcheongwl: Why do we need to ensure that access to COVID-19 treatments, vaccines, tests, and other technologies are not restricted b…
Why do we need to ensure that access to COVID-19 treatments, vaccines, tests, and other technologies are not restricted by commercial and nationalistic interests? @ellenthoen puts it plainly in her article in Nature Medicine: https://t.co/djJcRVaVSQ
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @carlhcoleman: @ellenthoen argues that "products for the prevention and treatment of COVID-19 should be global public goods." Protect a…
@MedsWatch Affordable access is the best remedy against fake Covid cures
RT @carlhcoleman: @ellenthoen argues that "products for the prevention and treatment of COVID-19 should be global public goods." Protect a…
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @gmdutfield: Ellen t’Hoen - Protect against market exclusivity in the fight against COVID-19 — Nature Medicine https://t.co/MIIJGygnnm
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
Protect against market exclusivity in the fight against COVID-19 https://t.co/gxDef98R6O
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @ValeriaHuisman: How to ensure sufficient production of treatments and vaccines against COVID-19 and and accessibility for all?
RT @DrRimmer: Protect against market exclusivity in the fight against https://t.co/NNcl3JlZ6A #COVID19 Patents and other intellectual prop…
RT @DrRimmer: Protect against market exclusivity in the fight against https://t.co/NNcl3JlZ6A #COVID19 Patents and other intellectual prop…
Ellen t’Hoen - Protect against market exclusivity in the fight against COVID-19 — Nature Medicine https://t.co/MIIJGygnnm
RT @jamie_love: From @ellenthoen in @nature, on the Costa Rica proposal for a WHO COVID 19 technology pool. Protect against market exclu…
RT @jamie_love: From @ellenthoen in @nature, on the Costa Rica proposal for a WHO COVID 19 technology pool. Protect against market exclu…
RT @ekuischlaroche: Proud of Costa Rica 🇨🇷 for its stance on Open Science! #UNESCO supports Open Science platforms and int’l scientific coo…
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
Protect against market exclusivity in the fight against COVID-19 | Nature Medicine https://t.co/ZmigG7zsv6
@ellenthoen argues that "products for the prevention and treatment of COVID-19 should be global public goods." Protect against market exclusivity in the fight against COVID-19 | Nature Medicine https://t.co/coF4oGwK0b
RT @jamie_love: From @ellenthoen in @nature, on the Costa Rica proposal for a WHO COVID 19 technology pool. Protect against market exclu…
RT @jamie_love: From @ellenthoen in @nature, on the Costa Rica proposal for a WHO COVID 19 technology pool. Protect against market exclu…
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @jamie_love: From @ellenthoen in @nature, on the Costa Rica proposal for a WHO COVID 19 technology pool. Protect against market exclu…
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
How to ensure sufficient production of treatments and vaccines against COVID-19 and and accessibility for all?
RT @wimdeceuk: "The #COVID19 technology pool should be front and center in the strategy against COVID-19 to ensure that once medicines and…
Czy "Nature" też zaraz okaże się wrogą ludzkości gazetą? 🤔
RT @jamie_love: From @ellenthoen in @nature, on the Costa Rica proposal for a WHO COVID 19 technology pool. Protect against market exclu…
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
RT @jamie_love: From @ellenthoen in @nature, on the Costa Rica proposal for a WHO COVID 19 technology pool. Protect against market exclu…
RT @ellenthoen: My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywal…
"The #COVID19 technology pool should be front and center in the strategy against COVID-19 to ensure that once medicines and vaccines become available, intellectual property will not be the barrier to making them accessible for all in need." - @ellenthoen
Important read!
RT @jamie_love: From @ellenthoen in @nature, on the Costa Rica proposal for a WHO COVID 19 technology pool. Protect against market exclu…
My article ‘Protect against market exclusivity in the fight against COVID-19’ published today in @NatureMedicine (no paywall) https://t.co/UXei2I6e2x @UNITAID @MedsPatentPool
From @ellenthoen in @nature, on the Costa Rica proposal for a WHO COVID 19 technology pool. Protect against market exclusivity in the fight against COVID-19 https://t.co/JWId2Pb8Vz
"The COVID-19 technology pool should be front and center in the global community’s strategy against COVID-19 to ensure that once medicines and vaccines become available, [IP] will not be the barrier to making them accessible for all in need." - @ellenthoen
RT @julienpotet: "Protect against market exclusivity in the fight against #COVID19". Words of wisdom by @ellenthoen. https://t.co/EUcwpolTci
"Protect against market exclusivity in the fight against #COVID19". Words of wisdom by @ellenthoen. https://t.co/EUcwpolTci
#NatureMedicine Protect against market exclusivity in the fight against COVID-19 https://t.co/w9EA5qpLVt